RIOK2 and cancer: As illustrated in Figure 4B, the degree of methylation at the RIOK2 promoter region was significantly and negatively correlated with overall survival in most cancer patients, indicating that the hypermethylation of RIOK2 in the TSS1500 region may inhibit the occurrence and development of tumors by inhibiting the expression of RIOK2.